維力醫療(603309.SH):擬推500萬股的第一期限制性股票激勵計劃
格隆匯11月5日丨維力醫療(603309.SH)發佈第一期限制性股票激勵計劃(草案),擬向激勵對象授予500萬股限制性股票,約佔草案公吿時公司股本總額的1.92%。
其中,首次授予403萬股,約佔草案公吿時公司股本總額的1.55%,佔擬授予權益總額的80.60%;預留授予97萬股,約佔草案公吿時公司股本總額的 0.37%,佔擬授予權益總額的19.40%。
該激勵計劃授予的限制性股票(含預留)的授予價格為6.39元/股。即,滿足授予條件之後,激勵對象可以每股6.39 元的價格購買公司定向發行的A股普通股股票。
該激勵計劃首次授予的激勵對象不超過108人,約佔公司(含子公司)截止2020年12月31日員工總數2755人的3.92%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.